Access


Rise Wellness is based in Canada



The Special Access Program (SAP) allows for pharmaceutical options that would otherwise be unavailable to Canadian residents, when other therapies have failed, are unsuitable, or are unavailable. Currently, many patients, healthcare professionals and doctors have been granted exemptions for the use of psilocybin for end-of-life therapy and PTSD. You can find out more at https://therapsil.ca

Health Canada is considering implementing a Special Access Program for how they deal with some of the recognized medical treatments that fall outside of the scope of approved Canadian therapies.

The SAP lives in Part C of the Food and Drug Regulations (FDR). It includes psilocybin, MDMA, LSD, DMT, and their analogs.
Please let us know if you would like more information on how to apply here.